BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20516698)

  • 1. Reduced kidney function estimated by cystatin C and clinical outcomes in hypertensive patients with coronary artery disease: association with homocysteine and other cardiovascular risk factors.
    Dzielinska Z; Januszewicz A; Wiecek A; Prejbisz A; Zielinski T; Chudek J; Makowiecka-Ciesla M; Demkow M; Tyczynski P; Januszewicz M; Ruzyllo W; Naruszewicz M
    Kidney Blood Press Res; 2010; 33(2):139-48. PubMed ID: 20516698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study.
    Keller T; Messow CM; Lubos E; Nicaud V; Wild PS; Rupprecht HJ; Bickel C; Tzikas S; Peetz D; Lackner KJ; Tiret L; Münzel TF; Blankenberg S; Schnabel RB
    Eur Heart J; 2009 Feb; 30(3):314-20. PubMed ID: 19153178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine and progression of coronary artery disease.
    Skibińska E; Sawicki R; Lewczuk A; Prokop J; Musiał W; Kowalska I; Mroczko B
    Kardiol Pol; 2004 Mar; 60(3):197-205. PubMed ID: 15156215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum cystatin C is an independent predictor of cardiovascular events in people with relatively normal renal function.
    Meng L; Yang Y; Qi LT; Wang XJ; Xu GB; Zhang BW
    J Nephrol; 2012; 25(3):426-30. PubMed ID: 21928225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
    Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between serum homocysteine, vitamin B12, folate and Thai coronary artery disease patients.
    Leowattana W; Mahanonda N; Bhuripunyo K; Pokum S
    J Med Assoc Thai; 2000 May; 83(5):536-42. PubMed ID: 10863900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystatin C levels are associated with the prognosis of systolic heart failure patients.
    Gao C; Zhong L; Gao Y; Li X; Zhang M; Wei S
    Arch Cardiovasc Dis; 2011 Nov; 104(11):565-71. PubMed ID: 22117908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 24-h blood pressure measurement may predict mortality and cardiovascular events in hypertensive patients with coronary artery disease.
    Dzielińska Z; Prejbisz A; Makowiecka-Cieśla M; Januszewicz A; Tyczyński P; Demkow M; Zieliński T; Kadziela J; Florczak E; Ruzyłło W
    Blood Press Monit; 2009 Jun; 14(3):99-102. PubMed ID: 19417635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of elevated homocysteine levels with a higher risk of recurrent coronary events and mortality in patients with acute myocardial infarction.
    Matetzky S; Freimark D; Ben-Ami S; Goldenberg I; Leor J; Doolman R; Novikov I; Eldar M; Hod H
    Arch Intern Med; 2003 Sep; 163(16):1933-7. PubMed ID: 12963566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
    Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cystatin C and adiponectin in diabetics with and without coronary artery disease].
    Wolff C; Durruty P; Espinoza J; Ripamonti S; Díaz J
    Rev Med Chil; 2009 Jun; 137(6):729-36. PubMed ID: 19746273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cystatin C and cardiovascular risk in the general population].
    Cepeda J; Tranche-Iparraguirre S; Marín-Iranzo R; Fernández-Rodríguez E; Riesgo-García A; García-Casas J; Hevia-Rodríguez E
    Rev Esp Cardiol; 2010 Apr; 63(4):415-22. PubMed ID: 20334807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance and inflammation may have an additional role in the link between cystatin C and cardiovascular disease in type 2 diabetes mellitus patients.
    Lee SH; Park SA; Ko SH; Yim HW; Ahn YB; Yoon KH; Cha BY; Son HY; Kwon HS
    Metabolism; 2010 Feb; 59(2):241-6. PubMed ID: 19765773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of troponin T and homocysteine in patients with end-stage renal disease.
    Sahinarslan A; Güz G; Okyay K; Mutluay R; Yalçin R; Bali M; Sindel S; Cengel A
    Turk Kardiyol Dern Ars; 2008 Sep; 36(6):382-7. PubMed ID: 19155641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of cystatin C and prognosis following admission for acute heart failure.
    Campbell CY; Clarke W; Park H; Haq N; Barone BB; Brotman DJ
    Am J Cardiol; 2009 Aug; 104(3):389-92. PubMed ID: 19616673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between plasma homocysteine levels and coronary artery disease: a population-based study in northern Greece.
    Boufidou AI; Makedou AD; Adamidis DN; Karvounis HI; Gourassas JT; Kesidis HT; Makedou KG; Papadopoulos CE; Parharidis GE; Louridas GE
    Curr Med Res Opin; 2004; 20(2):175-80. PubMed ID: 15006011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma pyridoxal 5'-phosphate and high-sensitivity C-reactive protein are independently associated with an increased risk of coronary artery disease.
    Cheng CH; Lin PT; Liaw YP; Ho CC; Tsai TP; Chou MC; Huang YC
    Nutrition; 2008 Mar; 24(3):239-44. PubMed ID: 18312786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma homocysteine: an independent or an interactive risk factor for coronary artery disease.
    Gupta M; Sharma P; Garg G; Kaur K; Bedi GK; Vij A
    Clin Chim Acta; 2005 Feb; 352(1-2):121-5. PubMed ID: 15653106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.